Philips announces WE-TRUST multicenter clinical trial to assess impact of `Direct to Angio Suite´ workflow on stroke patient outcomes
(WorldNews Belgium)

Philips announces WE-TRUST multicenter clinical trial to assess impact of `Direct to Angio Suite` workflow on stroke patient outcomes 27 Nov 2019 16:00 CET Company Name - ISN Market Symbol - Philips announces WE-TRUST multicenter clinical trial to assess impact of `Direct to Angio Suite` workflow on stroke patient outcomes November 27, 2019 Amsterdam, the Netherlands -Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a major clinical trial to assess the impact of a `Direct to Angio Suite` workflow on stroke patient outcomes. The study will assess whether with Philips` advanced image-guided therapy platform it is possible to diagnose, plan and treat...